RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+50.37%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.65B
AUM Growth
+$3.65B
(+51%)
Cap. Flow
+$447M
Cap. Flow
% of AUM
12.25%
Top 10 Holdings %
Top 10 Hldgs %
23.51%
Holding
147
New
14
Increased
83
Reduced
11
Closed
4
Top Buys
| 1 |
Novavax
NVAX
|
$47.6M |
| 2 |
Centene
CNC
|
$35.9M |
| 3 |
UnitedHealth
UNH
|
$31M |
| 4 |
Edwards Lifesciences
EW
|
$26.8M |
| 5 |
Royalty Pharma
RPRX
|
$24.3M |
Top Sells
| 1 |
FTSV
Forty Seven, Inc. Common Stock
FTSV
|
$42.7M |
| 2 |
Intuitive Surgical
ISRG
|
$18.5M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$7.9M |
| 4 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$7.48M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$5.41M |
Sector Composition
| 1 | Healthcare | 92.16% |
| 2 | Consumer Staples | 1.09% |
| 3 | Consumer Discretionary | 0.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNST
76
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $15.5M | 0.43% | 515,680 +282,180 | +121% | +$8.48M |
|
77
Guardant Health
GH
$8.41B
| $15.4M | 0.42% | 190,000 | – | – |
|
78
Amicus Therapeutics
FOLD
$2.34B
| $15.3M | 0.42% | 1,016,821 +16,821 | +2% | +$254K |
|
|
CVET
79
DELISTED
Covetrus, Inc. Common Stock
CVET
| $15M | 0.41% | 837,500 +816,817 | +3,949% | +$14.6M |
|
|
BHVN
80
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $14.9M | 0.41% | 203,817 +3,817 | +2% | +$279K |
|
81
Johnson & Johnson
JNJ
$427B
| $14.8M | 0.41% | 105,000 | – | – |
|
|
GWPH
82
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $14.7M | 0.4% | 120,043 +90,043 | +300% | +$11.1M |
|
83
Dynavax Technologies
DVAX
$1.19B
| $14.7M | 0.4% | 1,660,120 +85,120 | +5% | +$755K |
|
84
Spyre Therapeutics
SYRE
$996M
| $14.7M | 0.4% | 1,590,528 +790,528 | +99% | +$7.31M |
|
|
RDUS
85
DELISTED
Radius Health, Inc.
RDUS
| $13.7M | 0.38% | 1,003,259 +28,259 | +3% | +$385K |
|
|
MNTA
86
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $13.3M | 0.37% | 400,000 | – | – |
|
87
TG Therapeutics
TGTX
$4.65B
| $13.3M | 0.36% | +682,926 | New | +$13.3M |
|
|
PPD
88
DELISTED
PPD, Inc. Common Stock
PPD
| $13.1M | 0.36% | 487,500 +37,500 | +8% | +$1.01M |
|
89
CONMED
CNMD
$1.68B
| $13M | 0.36% | 180,000 | – | – |
|
90
FibroGen
FGEN
$47.8M
| $12.8M | 0.35% | 315,449 +9,449 | +3% | +$383K |
|
|
DCPH
91
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $12.5M | 0.34% | 209,829 -125,171 | -37% | -$7.48M |
|
92
Health Catalyst
HCAT
$239M
| $12.4M | 0.34% | 425,000 | – | – |
|
|
TBIO
93
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $11.9M | 0.33% | 661,268 -163,732 | -20% | -$2.93M |
|
94
Bright Horizons
BFAM
$6.71B
| $11.5M | 0.32% | +98,500 | New | +$11.5M |
|
95
Rhythm Pharmaceuticals
RYTM
$6.85B
| $11.4M | 0.31% | 512,111 +12,111 | +2% | +$270K |
|
|
ZGNX
96
DELISTED
Zogenix, Inc.
ZGNX
| $11.2M | 0.31% | 415,982 +15,982 | +4% | +$432K |
|
97
Immunovant
IMVT
$2.56B
| $11M | 0.3% | 452,319 +202,319 | +81% | +$4.93M |
|
98
Rigel Pharmaceuticals
RIGL
$697M
| $10.8M | 0.3% | 5,897,642 +397,642 | +7% | +$728K |
|
|
MYOV
99
DELISTED
Myovant Sciences Ltd.
MYOV
| $10.5M | 0.29% | 508,411 +8,411 | +2% | +$173K |
|
100
NovoCure
NVCR
$1.38B
| $10.4M | 0.28% | 175,000 | – | – |
|